557 results
Page 3 of 28
8-K
EX-2.1
jlh ji7mhw
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
m9bjiwcm
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.4
12wrnbsg41ul8q
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
425
EX-99.3
h5r1raqfa5c8l6 pi67s
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.1
m1rg wj76i21
23 Mar 22
Business combination disclosure
5:29pm
425
brvf6s4d
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.2
choz98499
23 Mar 22
Business combination disclosure
5:29pm
8-K
EX-99.3
kdozvhiiqg5nu98h
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
pdiuzmpgt5s 3guyrlhd
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
27of6
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.2
ffmp g7qt9z1k8p
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
pzs5kxig iekvep2
17 Feb 22
Ligand Reports Fourth Quarter and Full Year 2021 Financial Results
4:03pm
8-K
rp8cav93wmd dtl0iy
14 Jul 21
Ligand Pharmaceuticals Appoints Dr. Jennifer Cochran to its Board of Directors
4:08pm
8-K
kfe9fvd8uagehm ib
7 Jun 21
Submission of Matters to a Vote of Security Holders
12:00am
DEFA14A
32y3 pxqcubs
18 May 21
Additional proxy soliciting materials
5:00pm